Marex Group »

Apellis Pharmaceuticals shares owned by Marex Group

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Marex Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $578k 23k 25.12

More positions owned by Marex Group

Meta Platforms Cl A (META)
Tesla Motors (TSLA)
UnitedHealth (UNH)
NVIDIA Corporation (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Booking Holdings (BKNG)
Apple (AAPL)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Microsoft Corporation (MSFT)
Strategy Cl A New (MSTR)
Valkyrie Bitcoin (BRRR)
Home Depot (HD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Netflix (NFLX)

View all positions for Marex Group

Top funds holding Apellis Pharmaceuticals

venBio Select Advisor
Vanguard Group
Wellington Management Company
Deep Track Capital
Rtw Investments
BlackRock
State Street Corporation
AQR Capital Management
UBS Group
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors
Geode Capital Management
Jennison Associates

View all funds holding Apellis Pharmaceuticals